CSF1R and neoplasm: By contrast, anti-CSF-1R treatment did not reduce the effects of anti-PD-L1 + anti-TIGIT treatment on tumour Treg cells (Fig. 6c and Extended Data Fig. 9g), suggesting an alternative mechanism of action6.